Study of COM503 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called COM503 for people with advanced solid tumors that have not responded to or cannot be treated with standard therapies. It aims to see if the drug is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer (solid tumor) that has spread or come back and standard treatments either didn't work, are not suitable, or you couldn't tolerate them.
- Your tumor can be seen and measured on a CT or MRI scan.
- You have not had another cancer in the last 2 years (unless it was a low-risk cancer like certain skin cancers or early-stage cancer that was completely removed).
- You are not taking high-dose steroids (more than 10 mg of prednisone per day) or other strong immune-suppressing medicines.
- You do not have active cancer in your brain or spinal cord, or an active infection that needs treatment, or hepatitis B/C or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called IPN60300 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink tumors.
This trial tests a new drug called ZE94-0605 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if it is safe and can shrink tumors.
This trial tests an experimental drug called OR502, which targets a protein on immune cells, to see if it can help fight advanced solid tumors. It is given alone or with other anti-cancer drugs, and the study aims to find the best dose and see how well it works.
This trial tests a new drug called ZL-6201 for people with sarcoma or certain solid tumors that have spread or cannot be removed. It aims to see if the drug is safe and helps shrink tumors.
This trial tests a new drug (GRWD5769) that may help your immune system fight cancer. It is for people with advanced solid tumors that have stopped responding to standard treatments, including certain types of cervical, liver, and other cancers.
This study tests a new drug called LM-299 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if LM-299 is safe and effective.
Hear when a new Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.